Mayor Michelle Wu delivered her third annual State of the City speech Wednesday at MGM Music Hall. Her office shared her prepared remarks: Good evening, Boston! Thank you to our hosts at the MGM Music ...

Boston Mayor Michelle Wu presented her third annual State of the City Address on Wednesday evening, her first such speech during an election year.

Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Back in 2021, Vertex already said its intellectual property supported its leadership in the space into the late 2030s. All of this means there's reason to be confident about Vertex's ongoing ...

Vertex Pharmaceuticals will not advance clinical ... strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

In September 2023, the company had raised around $20 million (Rs 173.2 crore) in its Series B round of funding, led by Vertex Ventures. Fireside Ventures also participated in the round. In addition, ...

Its online service includes Web Trade VIA Vertex Aero. Its online platform for investors includes back-office client, mutual fund, online trade, commodity back office, equity back office and ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biopharmaceutical company with a market capitalization of $131.2 billion, has been making significant strides in the treatment of cystic fibrosis (CF) ...